Open access · CC-BY
via OpenAlex
Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus
Aifen Li, Fengbiao Guo, Quanren Pan, Jiaxuan Chen, Hua-feng Liu, Qingjun Pan
Frontiers in Immunology · 2021 · ▲ 118 citations
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Although previous studies have demonstrated that SLE is related to the imbalance of cells in the immune system, including B cells, T cells, and dendritic cells, etc., the mechanisms underlying SLE pathogenesis remain unclear. Therefore, effective and low side-effect therapies for SLE are lacking. Recently, mesenchymal stem cell (MSC) therapy for autoimmune diseases, particularly SLE, has gained increasing attention. This therapy can improve the signs and symptoms of refractory SLE by promoting the proliferation of Th2 and Treg cells and inhibiting the activity of Th1, Th17, and B cells, etc. However, MSC therapy is also reported ineffective in some patients with SLE, which may be related to MSC- or patient-derived factors. Therefore, the therapeutic effects of MSCs should be further confirmed. This review summarizes the status of MSC therapy in refractory SLE treatment and potential reasons for the ineffectiveness of MSC therapy from three perspectives. We propose various MSC modification methods that may be beneficial in enhancing the immunosuppression of MSCs in SLE. However, their safety and protective effects in patients with SLE still need to be confirmed by further experimental and clinical evidence.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fimmu.2021.728190
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Li, A., Guo, F., Pan, Q., Chen, J., Liu, H., & Pan, Q. (2021). Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus. <em>Frontiers in Immunology</em>. https://doi.org/10.3389/fimmu.2021.728190
Vancouver
Li A, Guo F, Pan Q, Chen J, Liu H, Pan Q. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus. Frontiers in Immunology. 2021. doi:10.3389/fimmu.2021.728190.
BibTeX
@article{aifen2021Mesenc,
title = {Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus},
author = {Aifen Li and Fengbiao Guo and Quanren Pan and Jiaxuan Chen and Hua-feng Liu and Qingjun Pan},
journal = {Frontiers in Immunology},
year = {2021},
doi = {10.3389/fimmu.2021.728190},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Advances in Wound Care 2016
Preprint · OA
Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy
Journal of Biomedical Science 2021
Open access · CC-BY
Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications
Advanced Science 2024
Open access · CC-BY
Mesenchymal Stem Cells‐Involved Strategies for Rheumatoid Arthritis Therapy
Cell Medicine 2018
Open access · CC-BY
The effect of age on stem cell function and utility for therapy
Frontiers in Immunology 2021
Open access · CC-BY
Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases
Science Translational Medicine 2017
Preprint · OA